Previous studies with KO mice have shown that that estrogen suppression is involved in SERT deficiency-induced obesity, insulin resistance, and impaired glucose tolerance, as in these mice, the aromatase (Cyp19a1) expression and levels of circulating 17β-estradiol were reduced [25]. Here, CYP19A1 is linked to obesity disorder.